Clinical Trials Sponsored by Institut Pierre Richet

Total 343 results

University of Notre Dame
Institut Pierre Richet; In2Care

Active, not recruiting

EaveTubes for Vector Control

Malaria

Côte D'Ivoire
Institut de Recherche pour le Developpement
Institut de Recherche en Sciences de la Sante, Burkina Faso; Institut Pierre...

Unknown

Insecticide Resistance Management in Burkina Faso and Côte d'Ivoire (REACT)

Malaria
Institut Curie
Hoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre Laboratories

Active, not recruiting

Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients (PRECIS)

Primary Central Nervous System Lymphoma

France
Pierrel Research Europe GmbH
Roche Pharma AG

Terminated

Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation (CONVINCE)

Allogeneic Stem Cell Transplantation

Austria, Germany, Spain
Institut de Recherche pour le Developpement
Institut de Recherche en Sciences de la Sante, Burkina Faso; Expertise France; Institut Pierre Richet

Recruiting

Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities (REACT-2)

Malaria

Burkina Faso, Côte D'Ivoire
London School of Hygiene and Tropical Medicine
University of Nevada, Las Vegas; University of Ottawa; Institut Pierre Richet

Not yet recruiting

Net Transition Initiative: Efficacy of Two Next-generation Nets for Control of Malaria in Cote d'Ivoire

Malaria
UNICANCER
AstraZeneca; National Cancer Institute, France; Pierre Fabre Laboratories

Active, not recruiting

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours (MOVIE)

Breast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid Tumours

France
Centre Oscar Lambret
National Cancer Institute, France; Pierre Fabre Laboratories

Completed

Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma (OVIMA-1210)

Low-Grade Glioma

France
University Hospital, Brest
Roche Farma, S.A; Pierre Fabre Medicament; Groupe Francais De Pneumo-Cancerologie

Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer (VinMetAtezo)

Non-small Cell Lung Cancer

France
University Hospital, Montpellier
Paediatric Cardiology and Rehabilitation Unit, St-Pierre Institute

Completed

Physical Activity in Children With Inherited Cardiac Diseases

Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Brugada Syndrome | Long QT Syndrome | Catecholaminergic Polymorphic Ventricular Tachycardia

France
Institut de Recherche pour le Developpement
Foundation for Innovative New Diagnostics; Programme National de lutte contre... and other collaborators

Completed

Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis (SpeSerTryp)

Sleeping Sickness | Human African Trypanosomiasis | Trypanosoma Brucei Gambiense; Infection | West African Sleeping Sickness

Côte D'Ivoire, Guinea
Institut National de Recherche pour l'Agriculture...
Hospital Avicenne; Adeprina; Institut de Recherche Pierre Fabre

Completed

Effect of Arginine Supplementation in the Metabolic Syndrome

Overweight | Hypertriglyceridemic Waist

France
Institut National de Recherche pour l'Agriculture...
Hospital Avicenne; Adeprina; Institut de Recherche Pierre Fabre

Completed

Characterization of the Metabolic Fate of an Oral Arginine Form

Overweight | Hypertriglyceridemic Waist

France
Institut Investigacio Sanitaria Pere Virgili

Completed

Statin Therapy and COVID-19 Infection (STACOV)

Cardiovascular Diseases | COVID | Statin

Spain
Institut Investigacio Sanitaria Pere Virgili

Terminated

Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression (LIDEAL)

Alzheimer's Disease

Spain
Institut Investigacio Sanitaria Pere Virgili

Active, not recruiting

Effects of Almond Consumption on Innate and Adaptive Immune System (AlmondIS)

Immune System

Spain
Institut Investigacio Sanitaria Pere Virgili

Withdrawn

Telematic Model Integrated in the Transversal Care of the Secondary Prevention of Patients With Stroke

Stroke | Risk Factor, Cardiovascular

Spain
Institut Investigacio Sanitaria Pere Virgili

Completed

The Multidisciplinary Treatment of Fibromyalgia.

Quality of Life | Pain | Fibromyalgia | Treatment
Institut Investigacio Sanitaria Pere Virgili

Completed

Dairy Consumption and Overweight and Obesity in Children and Adolescents: a Meta-analysis.

Obesity, Childhood | Overweight and Obesity | Overweight, Childhood

Spain
Institut Investigacio Sanitaria Pere Virgili

Not yet recruiting

Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases (PREHABMET)

Neoadjuvant Therapy | Liver Metastases | Prehabilitation

Spain
Institut Investigacio Sanitaria Pere Virgili

Recruiting

Early Detection of Familial Hypercholesterolemia in Children (DECOPIN)

Familial Hypercholesterolemia | Familial Hypercholesterolemia - Homozygous | Familial Hypercholesterolemia - Heterozygous

Spain
Institut Investigacio Sanitaria Pere Virgili

Completed

Management of Psychological and Behavioral Symptoms in Patients With Dementias (PRESTA)

Dementia | Family Relations | Psychological and Behavioral Symptoms

Spain
Institut Investigacio Sanitaria Pere Virgili

Completed

Energy -Sensing Metabolites in Caloric Restriction

Obesity | Insulin Sensitivity/Resistance | Diabetes Type 2

Spain
Institut Investigacio Sanitaria Pere Virgili

Completed

Lung Ultrasound to Guide Surfactant Therapy (ECOSURF)

Respiratory Distress Syndrome

Spain
Institut de Médecine et d'Epidémiologie Appliquée...
Pierre and Marie Curie University

Recruiting

Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication (BICOLDER)

HIV Infections

France
Institut de Myologie, France
Institut Roche

Completed

Prospective Study of the Natural History of Patients With Type 2 and 3 Spinal Muscular Atrophy (NatHis-SMA)

Type 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular Atrophy

Belgium, France, Germany
Istituto Scientifico Romagnolo per lo Studio e...
Pierre Fabre Laboratories

Terminated

Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression (HighTySy)

Carcinoma, Non-Small-Cell Lung | Secondary | Advanced Stage IIIB | High Thymidylate Synthase Expression

Italy
Sierra Neurovision
CEISO; Institut des Sciences de la Vision

Not yet recruiting

Performance and Safety Evaluation of the S360 Medical Device Software. (ArgoS360)

Binocular Vision Disorder | Binocular Eye Movement Disorder | Ocular Motion; Disorder

France
Jean-Pierre Routy

Recruiting

Letermovir in ART-treated HIV-infected Persons (Letermovir)

People Living With HIV

Canada
Puerta de Hierro University Hospital
Carlos III Health Institute

Unknown

Efficacy of Double Wire Technique in Difficult Cases of Common Bile Duct Cannulation in ERCP (UDOGUIA-04)

Bile Duct Diseases

Spain
Centre Hospitalier Universitaire Saint Pierre
Institute for Medical Immunology (IMI); Laboratoire Hospitalier Universitaire...

Active, not recruiting

Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children (ELIKYA COVID)

Covid-19 | Pregnancy

Belgium
Institut National de Recherche pour l'Agriculture...
Riddet Institute

Completed

Influence of Protein Hydrolysis on Dietary Protein Digestibility and Metabolism in Healthy Subjects

Healthy

France
Institut Curie
Hoffmann-La Roche

Recruiting

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer (SKYLINE)

Triple Negative Breast Cancer

France
Maisonneuve-Rosemont Hospital
Issam Tanoubi; Mina Wahba Morcos; Pierre Drolet; Ariane Clairoux; Veronique Brulotte and other collaborators

Recruiting

Randomized, Controlled Trial Comparing the Effectiveness of Sedation-Epidural Anesthesia to Spinal Anesthesia in Outpatient Hip or Knee Arthroplasty. (RCT SEA vs SA)

Hip Injuries | Anesthesia | Knee Injuries and Disorders

Canada
Institut Investigacio Sanitaria Pere Virgili
Beneo GmbH

Completed

Effect of Inulin-type Fructans on Constipated Children. (CONSTICHILD)

Constipation

Spain
Ectycell SASU
Institut National de la Santé Et de la Recherche Médicale, France; Pierre and...

Completed

Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples (iQTEST)

Cardiology: RR / QT

France
Kirby Institute
Hoffmann-La Roche

Completed

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study (ASK-500)

HIV Infections

Australia
Institut Català d'Oncologia
Hoffmann-La Roche

Completed

Xeloda and Bevacizumab to Treat Rectal Cancer (xeberecto)

Rectal Cancer

Spain
Institut Claudius Regaud
Roche Pharma AG

Completed

Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Head and Neck Neoplasms

France
Institut Investigacio Sanitaria Pere Virgili
Western Pistachio Association

Completed

Effect of Pistachio Intake on Insulin Resistance and Type 2 Diabetes Mellitus (EPIRDEM)

Type 2 Diabetes Mellitus

Spain
Jules Bordet Institute
Hoffmann-La Roche; Breast International Group; Institut Curie; International Drug...

Suspended

De-escalation Adjuvant Chemo in HER2+/ER-/Node-neg Early BC Patients Who Achieved pCR After Neoadjuvant Chemo & Dual HER2 Blockade (Decrescendo)

HER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast Cancer

Korea, Republic of, France, Israel, Belgium, Switzerland, Australia
Centre Francois Baclesse
Roche Pharma AG; National Cancer Institute, France; Institut Curie

Completed

Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis

Metastatic Malignant Neoplasm to Brain

France
Barcelona Institute for Global Health
Bill and Melinda Gates Foundation; University of Sierra Leone; Ministry of Health...

Recruiting

Improving Care Through Azithromycin Research for Infants in Africa (ICARIA)

Child Mortality

Sierra Leone
Assistance Publique - Hôpitaux de Paris
Pierre and Marie Curie University; ANRS, Emerging Infectious Diseases; Institut...

Completed

Impact of the Fecal Flora Transplantation on Crohn's Disease (IMPACT-Crohn)

Crohn's Disease

France
Woodbury, Michel, M.D.
Lawson Health Research Institute

Completed

Open-label Study of Curcumin C-3 Complex in Schizophrenia

Depression | Schizophrenia | Schizoaffective Disorder

Puerto Rico
Jules Bordet Institute
Hoffmann-La Roche

Recruiting

A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients (COPERNIC)

Metastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer | Candidate for Third-line or Subsequent Lines of Therapy

Belgium, France
Jules Bordet Institute
Roche Pharma AG

Terminated

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 (I-SPARC)

Cancer

Belgium
Dana-Farber Cancer Institute
Roche-Genentech

Active, not recruiting

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Graft vs. Host Disease

United States
Jules Bordet Institute
Hoffmann-La Roche

Recruiting

Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) (ROSALINE)

HER2-negative Breast Cancer | ER+ Breast Cancer | Invasive Lobular Breast Carcinoma

Belgium, France
Jules Bordet Institute
Roche Pharma AG

Active, not recruiting

HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 (ZEPHIR)

HER-2 Positive Breast Cancer

Belgium, Netherlands

Clinical Trials Sponsored by Institut Pierre Richet

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations